Page last updated: 2024-11-13

scopularide a

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

scopularide A: found in the fungus Scopulariopsis brevicaulis, which was isolated from the marine sponge Tethya aurantium; structure in first source [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID24899412
CHEMBL ID507120
MeSH IDM0524643

Synonyms (2)

Synonym
CHEMBL507120
scopularide a

Research Excerpts

Overview

Scopularide A is a promising potent anticancer lipopeptide isolated from a marine derived Scopulariopsis brevicaulis strain.

ExcerptReferenceRelevance
"Scopularide A is a promising potent anticancer lipopeptide isolated from a marine derived Scopulariopsis brevicaulis strain. "( Identification of the Scopularide Biosynthetic Gene Cluster in Scopulariopsis brevicaulis.
Kempken, F; Kumar, A; Lukassen, MB; Saei, W; Sondergaard, TE; Sørensen, JL; Tamminen, A; Wiebe, MG, 2015
)
1.86

Effects

ExcerptReferenceRelevance
"Scopularide A production has been transferred from a non-agitated to a stirred tank bioreactor environment with an approximately 6-fold increase in specific and 29-fold increase in volumetric production. "( Production of scopularide A in submerged culture with Scopulariopsis brevicaulis.
Kramer, A; Labes, A; Tamminen, A; Wiebe, MG, 2014
)
2.21
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Bioassays (6)

Assay IDTitleYearJournalArticle
AID405484Antitumor activity against human HT29 cells assessed as reduction of viability at 10 ug/ml2008Journal of natural products, Jun, Volume: 71, Issue:6
Scopularides A and B, cyclodepsipeptides from a marine sponge-derived fungus, Scopulariopsis brevicaulis.
AID407494Antimicrobial activity against Escherichia coli2008Journal of natural products, Jun, Volume: 71, Issue:6
Scopularides A and B, cyclodepsipeptides from a marine sponge-derived fungus, Scopulariopsis brevicaulis.
AID407497Antitumor activity against human Colo357 cells assessed as reduction of viability at 10 ug/ml2008Journal of natural products, Jun, Volume: 71, Issue:6
Scopularides A and B, cyclodepsipeptides from a marine sponge-derived fungus, Scopulariopsis brevicaulis.
AID407495Antimicrobial activity against Pseudomonas fluorescens2008Journal of natural products, Jun, Volume: 71, Issue:6
Scopularides A and B, cyclodepsipeptides from a marine sponge-derived fungus, Scopulariopsis brevicaulis.
AID407496Antimicrobial activity against Candida glabrata2008Journal of natural products, Jun, Volume: 71, Issue:6
Scopularides A and B, cyclodepsipeptides from a marine sponge-derived fungus, Scopulariopsis brevicaulis.
AID405483Antitumor activity against human Panc89 cells assessed as reduction of viability at 10 ug/ml2008Journal of natural products, Jun, Volume: 71, Issue:6
Scopularides A and B, cyclodepsipeptides from a marine sponge-derived fungus, Scopulariopsis brevicaulis.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (7)

TimeframeStudies, This Drug (%)All Drugs %
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (14.29)29.6817
2010's6 (85.71)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 13.25

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index13.25 (24.57)
Research Supply Index2.08 (2.92)
Research Growth Index5.33 (4.65)
Search Engine Demand Index0.00 (26.88)
Search Engine Supply Index0.00 (0.95)

This Compound (13.25)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other7 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]